Literature DB >> 20184600

Subclinical hypercortisolism: correlation between biochemical diagnostic criteria and clinical aspects.

V Morelli1, B Masserini, A S Salcuni, C Eller-Vainicher, C Savoca, R Viti, F Coletti, G Guglielmi, C Battista, L Iorio, P Beck-Peccoz, B Ambrosi, M Arosio, A Scillitani, I Chiodini.   

Abstract

OBJECTIVE: Subclinical hypercortisolism (SH) has been associated with increased prevalence of hypertension, type 2 diabetes mellitus, dyslipidaemia, central obesity, osteoporosis and vertebral fractures. We aimed to investigate the accuracy of different SH diagnostic criteria in predicting the presence of complications.
DESIGN: This was a retrospective study. PATIENTS: We evaluated data from 231 patients (120 women and 111 men) affected with adrenal incidentalomas (AI). MEASUREMENTS: We studied the accuracy of different SH diagnostic criteria (cortisol after 1 mg overnight dexamethasone suppression test - 1mg-DST - at different cut-off such as 49.7, 82.8, 137.9 nmol/l, elevated urinary free cortisol, reduced adrenal corticotroph hormone (ACTH) levels alone or various combination of these parameters) in predicting the concomitant presence of the following three complications: hypertension, type 2 diabetes and vertebral fractures.
RESULTS: The criterion characterized by the presence of two of 1mg-DST >82.8 nmol/l, elevated UFC and reduced ACTH struck the best balance between sensitivity and specificity, reaching a good accuracy in predicting the cluster of complications (61.9%; 77.1% and 75.8%, respectively). The presence of this cluster was associated with this criterion (OR 4.75, 95%CI 1.8-12.7, P = 0.002) regardless of gonadal status, body mass index (BMI) and age.
CONCLUSIONS: The SH criterion characterized by the presence of two of 1mg-DST >82.8 nmol/l, elevated UFC and reduced ACTH seems the best in predicting the presence of chronic manifestations of subtle cortisol excess.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20184600     DOI: 10.1111/j.1365-2265.2010.03794.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  20 in total

1.  Urinary endogenous steroids and their relationships with BMD and body composition in healthy young males.

Authors:  Rafael Timon; Guillermo Olcina; Pablo Tomas-Carus; Armando Raimundo; Juan I Maynar; Marcos Maynar
Journal:  Endocrine       Date:  2012-01-15       Impact factor: 3.633

2.  Management of adrenocortical carcinoma: a consensus statement of the Italian Society of Endocrinology (SIE).

Authors:  A Stigliano; I Chiodini; R Giordano; A Faggiano; L Canu; S Della Casa; P Loli; M Luconi; F Mantero; M Terzolo
Journal:  J Endocrinol Invest       Date:  2015-07-14       Impact factor: 4.256

3.  DHEAS for the prediction of subclinical Cushing's syndrome: perplexing or advantageous?

Authors:  Serkan Yener; Hamiyet Yilmaz; Tevfik Demir; Mustafa Secil; Abdurrahman Comlekci
Journal:  Endocrine       Date:  2014-08-22       Impact factor: 3.633

4.  Six controversial issues on subclinical Cushing's syndrome.

Authors:  Iacopo Chiodini; Adriana Albani; Alberto Giacinto Ambrogio; Michela Campo; Maria Cristina De Martino; Giorgia Marcelli; Valentina Morelli; Benedetta Zampetti; Annamaria Colao; Rosario Pivonello
Journal:  Endocrine       Date:  2016-07-12       Impact factor: 3.633

5.  Health-related quality of life and fatigue in patients with adrenal incidentaloma.

Authors:  Darko Kastelan; Fedja Dzubur; Tina Dusek; Tamara Poljicanin; Zeljka Crncevic-Orlic; Ivana Kraljevic; Mirsala Solak; Tanja Bencevic; Izet Aganovic; Nikola Knezevic; Zeljko Kastelan; Mirko Korsic
Journal:  Endocrine       Date:  2011-03-26       Impact factor: 3.633

6.  The activity of 11β-hydroxysteroid dehydrogenase type 2 enzyme and cortisol secretion in patients with adrenal incidentalomas.

Authors:  Valentina Morelli; Elisa Polledri; Rosa Mercadante; Volha Zhukouskaya; Serena Palmieri; Paolo Beck-Peccoz; Anna Spada; Silvia Fustinoni; Iacopo Chiodini
Journal:  Endocrine       Date:  2015-10-05       Impact factor: 3.633

Review 7.  Endocrine incidentalomas--challenges imposed by incidentally discovered lesions.

Authors:  Dimitra A Vassiliadi; Stylianos Tsagarakis
Journal:  Nat Rev Endocrinol       Date:  2011-06-28       Impact factor: 43.330

Review 8.  Glucose metabolism in patients with subclinical Cushing's syndrome.

Authors:  Roberta Giordano; Federica Guaraldi; Rita Berardelli; Ioannis Karamouzis; Valentina D'Angelo; Elisa Marinazzo; Andreea Picu; Ezio Ghigo; Emanuela Arvat
Journal:  Endocrine       Date:  2012-03-06       Impact factor: 3.633

9.  Saliva versus serum cortisol to identify subclinical hypercortisolism in adrenal incidentalomas: simplicity versus accuracy.

Authors:  M Vieira-Correa; R B Giorgi; K C Oliveira; L F Hayashi; F A Costa-Barbosa; C E Kater
Journal:  J Endocrinol Invest       Date:  2019-08-27       Impact factor: 4.256

Review 10.  Adrenal incidentalomas and subclinical Cushing's syndrome.

Authors:  Dima Abdelmannan; David C Aron
Journal:  Rev Endocr Metab Disord       Date:  2010-06       Impact factor: 6.514

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.